Literature DB >> 21056976

The N-terminal fragment from caspase-cleaved serine/arginine protein-specific kinase2 (SRPK2) translocates into the nucleus and promotes apoptosis.

Yi Hong1, Sung-Wuk Jang, Keqiang Ye.   

Abstract

SRPK2 belongs to a family of serine/arginine (SR) protein-specific kinases (SRPKs), which phosphorylate SR domain-containing proteins in the nuclear speckles and mediate the pre-mRNA splicing. Previous studies have shown that SRPK2 plays a pivotal role in cell proliferation and apoptosis. However, how SRPK2 is regulated during the apoptosis is unclear. Here, we show that SRPK2 is cleaved by caspases at Asp-139 and -403 residues. Its N terminus cleaved product translocates into the nucleus and promotes VP16-induced apoptosis. Akt phosphorylation of SRPK2 prevents its apoptotic cleavage by caspases. 14-3-3β, the binding partner of Akt-phosphorylated SRPK2, further protects it from degradation. Hence, our results suggest that the N-terminal domain of SRPK2 cleaved by caspases translocates into the nucleus, where it promotes chromatin condensation and apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056976      PMCID: PMC3013036          DOI: 10.1074/jbc.M110.193441

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Localization of serine kinases, SRPK1 (SFRSK1) and SRPK2 (SFRSK2), specific for the SR family of splicing factors in mouse and human chromosomes.

Authors:  H Y Wang; K C Arden; J R Bermingham; C S Viars; W Lin; A D Boyer; X D Fu
Journal:  Genomics       Date:  1999-04-15       Impact factor: 5.736

2.  Regulated cellular partitioning of SR protein-specific kinases in mammalian cells.

Authors:  Jian-Hua Ding; Xiang-Yang Zhong; Jonathan C Hagopian; Marissa M Cruz; Gourisankar Ghosh; James Feramisco; Joseph A Adams; Xiang-Dong Fu
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

Review 3.  SR proteins and related factors in alternative splicing.

Authors:  Shengrong Lin; Xiang-Dong Fu
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

4.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

Review 5.  Proteases to die for.

Authors:  V Cryns; J Yuan
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

Review 6.  Alternative splicing and programmed cell death.

Authors:  Z H Jiang; J Y Wu
Journal:  Proc Soc Exp Biol Med       Date:  1999-02

7.  The structural basis for 14-3-3:phosphopeptide binding specificity.

Authors:  M B Yaffe; K Rittinger; S Volinia; P R Caron; A Aitken; H Leffers; S J Gamblin; S J Smerdon; L C Cantley
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

8.  Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation.

Authors:  S Sahara; M Aoto; Y Eguchi; N Imamoto; Y Yoneda; Y Tsujimoto
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

9.  Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors.

Authors:  Z H Jiang; W J Zhang; Y Rao; J Y Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1.

Authors:  Sung-Wuk Jang; Seung-Ju Yang; Asa Ehlén; Shaozhong Dong; Hanna Khoury; Jing Chen; Jenny L Persson; Keqiang Ye
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

View more
  6 in total

1.  Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.

Authors:  Zhi-Hao Wang; Pai Liu; Xia Liu; Fredric P Manfredsson; Ivette M Sandoval; Shan Ping Yu; Jian-Zhi Wang; Keqiang Ye
Journal:  Mol Cell       Date:  2017-08-17       Impact factor: 17.970

2.  Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma.

Authors:  Tzu-An Liu; Yee-Jee Jan; Bor-Sheng Ko; Shyh-Chang Chen; Shu-Man Liang; Ya-Lin Hung; Chiun Hsu; Tang-Long Shen; Yen-Ming Lee; Pei-Feng Chen; John Wang; Song-Kun Shyue; Jun-Yang Liou
Journal:  Am J Pathol       Date:  2011-10-01       Impact factor: 4.307

3.  SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease.

Authors:  Yi Hong; Chi Bun Chan; Il-Sun Kwon; Xuekun Li; Mingke Song; Hyun-Pil Lee; Xia Liu; Pradoldej Sompol; Peng Jin; Hyoung-gon Lee; Shan Ping Yu; Keqiang Ye
Journal:  J Neurosci       Date:  2012-11-28       Impact factor: 6.167

4.  An RS motif within the Epstein-Barr virus BLRF2 tegument protein is phosphorylated by SRPK2 and is important for viral replication.

Authors:  Melissa Duarte; Lili Wang; Michael A Calderwood; Guillaume Adelmant; Makoto Ohashi; Jennifer Roecklein-Canfield; Jarrod A Marto; David E Hill; Hongyu Deng; Eric Johannsen
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

5.  Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).

Authors:  Raoni Pais Siqueira; Éverton de Almeida Alves Barbosa; Marcelo Depólo Polêto; Germanna Lima Righetto; Thiago Vargas Seraphim; Rafael Locatelli Salgado; Joana Gasperazzo Ferreira; Marcus Vinícius de Andrade Barros; Leandro Licursi de Oliveira; Angelo Brunelli Albertoni Laranjeira; Márcia Rogéria Almeida; Abelardo Silva Júnior; Juliana Lopes Rangel Fietto; Jörg Kobarg; Eduardo Basílio de Oliveira; Robson Ricardo Teixeira; Júlio César Borges; Jose Andrés Yunes; Gustavo Costa Bressan
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

6.  Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies.

Authors:  Zhi-Hao Wang; Pai Liu; Xia Liu; Shan Ping Yu; Jian-Zhi Wang; Keqiang Ye
Journal:  J Exp Med       Date:  2018-10-29       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.